4basebio PLC (AIM:4BB)
London · Delayed Price · Currency is GBP · Price in GBX 870.00
+15.00 (1.75%)
Sep 9, 2025, 8:36 AM GMT+1
4basebio Market Cap
4basebio has a market cap or net worth of 132.33 million as of September 9, 2025. Its market cap has decreased by -29.70% in one year.
Market Cap
132.33M
Enterprise Value
112.72M
Revenue
933.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
870.00
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 132.33M, an increase of 218.32%. That is a compound annual growth rate of 28.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 132.33M | -14.59% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
| Feb 17, 2021 | 41.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.62B |
| GSK plc | 58.98B |
| Haleon | 32.14B |
| Smith & Nephew | 12.27B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.76B |
| HUTCHMED (China) | 1.98B |
| Genus | 1.75B |